AZO vs LAB · P/E 21, rev $18.94B vs rev $174.4M
AutoZone Inc (AZO) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
AutoZone Inc (AZO) is a auto parts company listed on NYSE.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported AZO revenue for 2025-08-30 was $18.94B. Net income was $2.50B. Revenue was up 2.4% from 2024-08-31 to 2025-08-30. AZO currently screens at market cap $50.08B and trailing P/E 21.0.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
AZO currently screens at market cap $50.08B and trailing P/E 21.0. LAB currently screens at market cap $317.1M.
Not investment advice. Open the AZO and LAB stock pages for the full models.
Not investment advice.